Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and ...

They wanted to help but there wasn’t really anything they could confidently do.” Her family researched other treatment ...

The Rotorua woman is going to the US this month for surgery and radiation, costing about $550,000. It was a “hard decision” ...

They studied 36 FFPE samples from patients with meningioma—a common and benign brain tumor—and used a novel computational approach to integrate this data with nearly 1,300 publicly available ...

The patient - Adan (name changed) - presented with symptoms of left-sided weakness persisting for a year and headaches ...

They studied 36 FFPE samples from patients with meningioma – a common and benign brain tumor – and used a novel computational approach to integrate this data with nearly 1,300 publicly ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...

A Frankfort teen is kicking cancer's butt thanks to St Jude Children's Research Hospital and the generosity of Central New ...